Credits: Canva
A recent study suggests that people who donate blood regularly may have genetic changes in their blood that could in fact reduce the risk of developing cancer. It is conducted by the researchers at the Francis Crick Institute, and the study has now provided new insights into how and why blood cancers develop. The study is published in the journal Blood and was conducted by the scientists from Heidelberg and the German Red Cross blood donation center. There is yet a need for further research to confirm these findings.
The researchers examined the blood of two groups of healthy male donors in their 60s:
The goal was to analyze genetic mutations in their blood and assess whether frequent donation had any impact on their genetic makeup.
As and when people age, their blood and other cells naturally develop mutations and some of them can also increase the risk of cancer. When anyone donates blood, his or her body compensates by producing new blood cells, which can influence the genetic diversity of stem cells in the bone marrow. The study also found that both groups had a similar number of mutations. For instance the frequent donors had 217 mutations, while the irregular donors had 212 mutations.
However, the nature of these mutations differed. In the frequent donors, 50% of the mutations were of a type not associated with a high risk of blood cancers, compared to only 30% in the irregular donors.
Further laboratory analysis showed that these specific mutations behaved differently from those linked to leukemia, a type of blood cancer. When human blood stem cells with these mutations were injected into mice, they were found to be highly effective at producing red blood cells, which is considered a positive outcome.
Dr. Hector Huerga Encabo, one of the study authors, emphasized that these mutations do not indicate an increased risk of leukemia. The findings suggest that regular blood donation may influence how stem cells evolve, but whether this translates into a lower cancer risk remains uncertain.
Read More: Who Can Donate Blood To Whom?
One notable disadvantage is the "healthy-donor effect"—because blood donors are often healthier than the general population, their lower cancer risk could be unrelated to blood donation.
Dominique Bonnet, senior researcher and head of a stem-cell laboratory at the Francis Crick Institute, stressed the need for larger studies with female volunteers to confirm the findings.
Despite ongoing research into potential health benefits for donors, the primary goal of blood donation remains saving lives. NHS Blood and Transplant emphasized that while the study is interesting, further research is required to draw firm conclusions. The organization also noted that blood supplies are currently critically low and encouraged eligible individuals to donate.
Also Read: How Long After a Tattoo or Piercing Can I Donate Blood?
Credits: Britannica
Five weeks after the launch of Novo Nordisk's weight loss pill, Wegovy, 38,220 US prescriptions have been reported by IQVIA for the same. The company shares too climbed up by 4% on Friday, and touched the levels last seen in October.
The oral version of the Wegovy pill became available to US patients earlier this month after the US Food and Drug Administration (FDA) approved it in December.
After injection by Novo Nordisk, of the same name, Wegovy, which has been on the market since 2021, its popularity grew so much that it was in short supply until February 2025. The pill version has now come out, which many experts believe will expand its accessibility. As the monthly supply of pill is expected to be cheaper than the monthly supply of the weight loss injection.
A study published in the New England Journal of Medicine show that a 25 milligram Wegovy pill led to 13.6% reduction in weight on average over 64 weeks. When compared to placebo, the result was only 2.2% of weight loss. Novo Nordisk says that those who stayed on the treatment and reduced their calorie intake, it would lead to a loss of 16.6% of their weight.
The first step lies in buying the correct and safe weight loss pill. Make sure the weight loss pills are clinically proven option for people to use to reduce their weight.
Take the pill with a glass of water. Make sure to always have the pill prescribed and follow the instructions that you GP has told. Store the pill in a cold place, however avoid freezing the medicine. Keep the medicine out of a child's reach. In some weight loss pills, if you miss your dosage, you can take it within 1 hour, however, clarify these doubts from your GP. A pill can usually be consumed within an hour of a fat-containing meal up to three times a day., however, the Wegovy pill must be taken on an empty stomach. Patients are advised not to eat, drink, or take other medicines for at least 30 minutes afterward. Thus, one must follow what is being prescribed for the best result, as the administering of the pill could vary based on the medication.
Most importantly, a healthy balanced diet, and a regular workout routine is also important will the person is on the pill.
Read: Wegovy Starter Dose Now Available As Daily Pill, Replacing Weekly Injections
Digestive problems such as nausea and vomiting remain the most common side effects of GLP-1 drugs. These issues were also reported in studies of the pill versions. Around 7 percent of participants taking the Wegovy pill stopped treatment because of side effects, compared with 6 percent in the placebo group. In orforglipron’s trial, up to 10 percent of patients discontinued treatment, compared with 3 percent on placebo.
One key difference lies in how the medications are used. The Wegovy pill must be taken on an empty stomach with a small amount of water. Patients are advised not to eat, drink, or take other medicines for at least 30 minutes afterward. Doctors say this requirement has limited the use of Rybelsus, the pill form of semaglutide approved for diabetes, compared with Ozempic.
Eli Lilly highlights that orforglipron was taken once daily in trials without restrictions on food or water, which may make it easier for patients to use consistently.
Credits: Canva
On February 13, Canadians across the country mark Wear Red Canada Day, a reminder that heart disease remains the leading cause of death for women. Yet despite the scale of the problem, many women still do not recognize their risk or their symptoms.
“We’re learning more and more each day about how heart disease uniquely affects women,” said nurse practitioner and researcher Rachel Ollivier in an interview with CTV News. She emphasized that awareness is still lagging, both among patients and within health-care systems.
According to the World Health Organization, cardiovascular disease accounts for roughly one in three deaths among women globally. In Canada, heart disease and stroke continue to be leading causes of death among women, and women are less likely than men to receive timely diagnosis or treatment.
Chest pain remains the most common heart attack symptom in both men and women. But Ollivier explained that women’s symptoms can often be subtler or feel different.
“For women, they often uniquely experience chest pain that seems like more of a discomfort or a tightness in the chest,” she said. Some women may feel pain in the left arm or jaw, unusual fatigue, nausea, vomiting, or discomfort between the shoulder blades.
Because these symptoms can be less specific, they are sometimes dismissed as stress, anxiety, indigestion, or exhaustion. Social factors also play a role. Women often juggle multiple responsibilities at home and work, and may delay seeking care. In some cases, their concerns may also be minimized within health-care settings.
Medical differences matter too. Women typically have smaller hearts and arteries, and plaque buildup behaves differently compared to men. Conditions such as spontaneous coronary artery dissection and microvascular dysfunction are seen more commonly in women, making diagnosis more complex.
Beyond symptoms, experts are urging greater recognition of the role hormones play in lifelong heart health.
“Endogenous estrogen is cardio protective,” Ollivier explained. As women enter the perimenopausal transition, estrogen levels fluctuate and gradually decline, and that protection is lost. This shift can lead to higher cholesterol levels and changes in fat distribution, increasing cardiovascular risk, particularly between the ages of 40 and 60.
Colleen Norris, a nursing professor at the University of Alberta and research lead of the CKHui LHHW Women’s Heart Health Research Collaborative who wrote on Yahoo Canada, believes the conversation needs to go even deeper.
She argues that ovaries have long been viewed only through the lens of reproduction. “The ovaries are not just reproductive organs. They are architects of women’s health across the lifespan,” she noted. Estrogen influences the heart and blood vessels, but also the brain, bones, kidneys, metabolism, and immune function.
Most women are never told that ovarian reserve and estrogen levels begin declining in their late 30s. By the time noticeable symptoms appear, biological changes may have already been underway for years.
Menopause itself is just one day, Norris explained. The larger reproductive transition surrounding it is what significantly increases vulnerability to chronic disease. Yet the health-care system often waits until disease develops before intervening.
Both experts stress that education is critical. Women with conditions such as polycystic ovary syndrome, pregnancy complications like preeclampsia or gestational diabetes, and those entering midlife should be particularly mindful of their cardiovascular risk.
Wear Red Canada Day is meant to spark awareness, but symbols alone are not enough. Experts are calling for better research funding focused on midlife women, improved medical education around ovarian aging, and more proactive screening during the reproductive transition.
Heart disease in women is not inevitable. But recognizing that symptoms can differ, and that hormonal shifts matter, could be lifesaving.
Credits: Canva
Seychelles Chikungunya Virus Outbreak: The United States warned travelers to be careful if they plan to visit the Seychelles islands anytime soon as it is currently undergoing a chikungunya outbreak. As per the Centers for Disease Control and Prevention (CDC), a 'Level 2' advisory for the island has been issued and travelers have been asked to 'practice enhanced precautions' if they do plan to visit.
Chikungunya is a mosquito-borne viral disease transmitted primarily by Aedes aegypti and Aedes albopictus, the same mosquitoes that spread dengue fever. Symptoms typically appear three to seven days after a bite and include sudden fever, severe joint pain, headache, nausea, fatigue, and rash in about half of cases.
However, there are certain unique symptoms of chikungunya. For instance, unlike a Dengue fever, chikungunya leaves lingering effects along with joint pain and fatigue that lasts up to weeks.
While common symptoms like high fever often >102 degree F is common there are other symptoms too, which includes:
Chikungunya symptoms usually occur with in 3 to 7 days after a bite. However, the symptoms could often last long. While fever could subside in a day or two, chronic symptoms especially like joint pain and muscle pain could last for months. Weakness too could persist.
A Level 2 travel advisory has been issued, which means the travelers are expected to practice enhanced precautions as compared to a Level 1 advisory that only asks travelers to practice usual precautions.
In more serious cases, Level 3 advisory is issued that asks travelers to reconsider non-essential travel, whereas a Level 4 advisory asks travelers to avoid all travel.
Read: CDC Travel Advisory Issued For These Islands Amid Chikungunya Outbreak
As CDC issues travel advisory, here is what travelers are expected to do:
© 2024 Bennett, Coleman & Company Limited